Procter & Gamble Analysts Raise Their Forecasts After Strong Q2 Earnings

Core Insights - Procter & Gamble Company reported mixed quarterly results, with adjusted earnings per share of $1.88, surpassing the analyst consensus estimate of $1.86, while quarterly sales of $22.208 billion fell short of the expected $22.282 billion [1] - The company anticipates a sales rebound in the next six months after experiencing what was described as the "softest quarter of the year" [1] Fiscal Guidance - Procter & Gamble reaffirmed its fiscal 2026 adjusted EPS guidance of $6.83 to $7.09, compared to the consensus estimate of $6.97, and maintained its sales outlook for fiscal 2026 at $85.127 billion to $88.498 billion, against the estimate of $86.823 billion [2] - The company reduced its fiscal 2026 GAAP earnings forecast, lowering the EPS outlook to $6.58 to $6.90 from a previous range of $6.71 to $7.09, which is below the consensus estimate of $6.91 [2] - Following the earnings announcement, Procter & Gamble shares increased by 0.9%, trading at $150.16 [2] Analyst Ratings and Price Targets - JP Morgan analyst Andrea Teixeira upgraded Procter & Gamble from Neutral to Overweight and raised the price target from $157 to $165 [4] - Wells Fargo analyst Chris Carey maintained an Overweight rating on Procter & Gamble and also raised the price target from $158 to $165 [4]